Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019)
Evotec SE's (EVO) quarterly Income from Non-Controlling Interests came in at $1.2 million in Q4 2019, up 316.52% quarter-over-quarter from -$550082.1 in Q3 2010.
Analysis
Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019) Analysis & Trends
Evotec SE has disclosed Income from Non-Controlling Interests across 3 years of filings, most recently posting $1.2 million for Q4 2019.
- In Q4 2019, Income from Non-Controlling Interests changed N/A year-over-year to $1.2 million; the TTM figure through Dec 2019 stood at $892312.7 (changed N/A YoY), while the FY2019 annual figure was $945219.1, changed N/A from the prior year.
- Income from Non-Controlling Interests came in at $1.2 million for Q4 2019 at Evotec SE, up from -$550082.1 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $1.2 million in Q4 2019 to a low of $1.2 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 2.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 722,000.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 19.44 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 1.19 Mn |
| Sep 30, 2010 | -550,082.14 |
| Jun 30, 2010 | 200,149.49 |
| Mar 31, 2010 | 51,234.26 |
| Dec 31, 2009 | 118,138.74 |
| Jun 30, 2009 | 247,819.99 |